QUODD

Insider Transactions last 24 months for Cellectar Biosciences, Inc. - NSDQ: CLRB

Transactions
All	Buy	Sell	Option Exercise

Filer's Name	Relationship/ Title	Trans. Date	Trans. Type	Ownership Type	Security Type	Shares	Price	Trans. Value	Total Shares Owned
Kolean Chad J	Chief Financial Officer	07/02/2025	AP	Direct	COM	5,000	$4.99	$24,950.00	6,418
Longcor Jarrod	Chief Operating Officer	07/02/2025	AP	Direct	COM	10,000	$4.99	$49,900.00	12,768
Caruso James V	Chief Executive Officer	07/02/2025	AP	Direct	COM	10,000	$4.99	$49,900.00	11,638
Longcor Jarrod	Chief Operating Officer	01/10/2025	AP	Direct	COM	30,000	$0.28	$8,400.00	83,141
Caruso James V	President and CEO	12/08/2023	AA	Direct	COM	40,596	$0.00	$0.00	49,236
Longcor Jarrod	Chief Operating Officer	12/08/2023	AA	Direct	COM	42,927	$0.00	$0.00	53,141
Shustov Andrei	Senior Vice President, Medical	12/08/2023	AA	Direct	COM	47,856	$0.00	$0.00	55,038
Kolean Chad J	Chief Financial Officer	12/08/2023	AA	Direct	COM	42,554	$0.00	$0.00	42,578
Lea Darrell Shane	Chief Commercial Officer	12/08/2023	AA	Direct	COM	39,599	$0.00	$0.00	39,599

1 You are at page 1 of 1 pages

Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security \| D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) \| E = Expiration of short derivative position \| F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. \| G = Gift \| H = Expiration (or cancellation) of long derivative position with value received \| I = Discretionary transaction in accordance with Rule 16b-3(f) \| J = Other \| L = Small acquisition under Rule 16a-6 \| M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 \| O = Exercise of out-of-the-money derivative security \| P = Open market or private purchase \| S = Open market or private sale \| U = Disposition pursuant to a tender of shares in a change of control transaction \| W = Acquisition or disposition by will or the laws of descent and distribution \| X = Exercise of in-the-money or at-the-money derivative security \| Z = Deposit into or withdrawal from voting trust		Send to Excel

Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust

Send to Excel